Aimei Health Technology Co., Ltd

NASDAQ:AFJK

Shell Companies

Financial Services
$11.96 -10.76%

-$3.66 today

Market cap
$73.22M
Beta
0.23
P/E (TTM)
34.3
EPS (TTM)
$0.88
52W Low $6.75High $130.37

Volume 0.13M

Average 0.02M

AFJK Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Aimei Health Technology Co., LtdNASDAQ: AFJK

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 152.1% from a year ago

Cash & equivalents stood at $18.52K at the end of Q1 FY2026, up 152.1% from a year earlier and up 532.2% from the prior quarter.

Context

  • Cash & equivalents amounted to 0.2% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
  • Cash & equivalents increased in 0 of the last 2 fiscal years.
  • FY2025 was the lowest annual figure in the 3 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +152.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$18.52K+532.2% QoQ
Last fiscal yearDec 2025
$2.93K-89.6% YoY
Year agoMar 2025
$7.35K+152.1% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+152.1%——
1 year-89.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
2.93K USD
Year-over-year change
-89.6%
2-year CAGR
-92.9%

Cash & Equivalents vs competitors

How AFJK compares with its peers on the latest reported figures

  • AFJK's Mar 2026 cash & equivalents of $18.52K is the 6th highest of the 8 companies compared; the peer median is $151.62K.
  • Its year-over-year change of +152.1% is the 2nd highest of 7, against a peer median of -30.9%.
  • Cash & equivalents amounts to 0.2% of total assets for AFJK, versus a peer median of 0.5%.
AFJK Competitors Peer median
Cash & Equivalents for AFJK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CPBICentral Plains Bancshares, Inc. Common StockDec 2025$7.73M +24.5%—1.4%
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary SharesMar 2026$2.8M +11108.6%—1.2%
ORIQUOrigin Investment Corp I UnitsMar 2026$834.11K ——1.1%
EURKEureka Acquisition Corp Class A Ordinary ShareMar 2026$151.62K -57.3%—0.5%
BAYABayview Acquisition Corp Class A Ordinary SharesMar 2026$50.19K -4.6%—0.4%
AFJKAimei Health Technology Co., LtdMar 2026$18.52K +152.1%—0.2%
UYSCUY Scuti Acquisition Corp.Dec 2025$8.85K -93.9%—0.0%
RIBBRibbon Acquisition CorpMar 2026$1.88K -99.6%—0.0%
Peer median (excluding AFJK) $151.62K-30.9%—0.5%

Competitors are the stored peer set for AFJK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD

Aimei Health Technology Co., Ltd

NASDAQ:AFJK

Intrinsic Alpha fair value

Locked

Current Price

$11.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.